These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4898807)

  • 1. [Therapeutic effect of trimethazone in patients with progressive polyarthritis. Preliminary communication].
    Trnavský K; Zbojanová M
    Vnitr Lek; 1969 Sep; 15(9):887-91. PubMed ID: 4898807
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.
    Lignière GC; Colombo B; Carrabba M; Ferrari P; Robotti E
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:253-8. PubMed ID: 4553232
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibility of using benzopyrazone in treatment of patients with progressive polyarthritis. (Preliminary report)].
    Trnavský K; Niepel G
    Fysiatr Revmatol Vestn; 1968 Dec; 46(6):348-51. PubMed ID: 5749832
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lonazolac-Calcium. A new non-steroidal antirheumatic agent for the treatment of progressive polyarthritis. A long-term open controlled trial].
    Pavelka K
    Fysiatr Revmatol Vestn; 1984 Apr; 62(2):80-7. PubMed ID: 6378745
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of mepirizole (DA-398) in the treatment of chronic rheumatoid arthritis].
    Shiokawa Y; Kageyama T; Sakuma A
    Ryumachi; 1973 Apr; 13(2):206-20. PubMed ID: 4581124
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the therapeutic action of flufenamic acid in patients with chronic polyarthritis in a double blind study].
    Mathies H; Eichhorn M
    Med Monatsschr; 1967 Nov; 21(11):510-6. PubMed ID: 4893773
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controlled clinical trial with Benetazone (Spofa) during spa treatment].
    Susta A; Pavelka K; Bremová A; Salavcová V; Svandová H; Richter M
    Fysiatr Revmatol Vestn; 1975 Feb; 53(1):3-11. PubMed ID: 1092603
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Dotti F; Ongari R; Carazzi R; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:265-8. PubMed ID: 4553235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
    de Sèze S; Dryll A; Dreiser R
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1425-8. PubMed ID: 4614819
    [No Abstract]   [Full Text] [Related]  

  • 10. [Various clinical and biohumoral effects of pyrasanone in rheumatoid arthritis].
    Glorioso S; Punzi L; Todesco S
    Clin Ter; 1976 Dec; 79(5):419-33. PubMed ID: 798649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clofezone, a new potent antirheumatic drug].
    Kaiser H
    Munch Med Wochenschr; 1973 Dec; 115(49):2247-8. PubMed ID: 4205416
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bufexamac in the treatment of progressive polyarthritis. Double-blind test using phenylbutazone, too].
    Pavelka K; Vojtísek O; Brémová A; Hándlová D; Kanková D; Králová M
    Cas Lek Cesk; 1972; 111(22):514-7. PubMed ID: 5031749
    [No Abstract]   [Full Text] [Related]  

  • 13. Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effects.
    Aylward M
    Br J Clin Pract; 1973 Jul; 27(7):255-60. PubMed ID: 4580332
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
    Scanni A; Ferrari P
    Minerva Med; 1973 Oct; 64(71):3718-24. PubMed ID: 4588363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of alclofenac and phenylbutazone effects in short-term therapy of chronic arthritis (double-blind test)].
    Pavelka K; Vojtísek O; Brémová A; Kanková D; Hándlová D
    Fysiatr Revmatol Vestn; 1973 Aug; 51(4):212-9. PubMed ID: 4578290
    [No Abstract]   [Full Text] [Related]  

  • 17. A new pyrazolidine derivative - benetazone spofa - in short- and medium-term treatment of rheumatoid arthritis. (Double-blind comparative study with phenylbutazone).
    Pavelka K; Vojtisek O; Bremová A; Kauková D; Hándlová D
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):20-8. PubMed ID: 61951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic polyarthritis with Sulindac].
    Vetter G; Picha B
    MMW Munch Med Wochenschr; 1977 Oct; 119(42):1369-70. PubMed ID: 412071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lonazolac - a new non-steroidal antirheumatic agent. Report of a double-blind crossover clinical study].
    Trnavský K; Bosmanský K
    Fysiatr Revmatol Vestn; 1983 Jun; 61(3):147-52. PubMed ID: 6350135
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders.
    Anylward M; Davies DB
    Br J Clin Pract; 1972 Nov; 26(11):517-23. PubMed ID: 4563533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.